In the mid-term performance, a "Davis Double Play" occurred, with Guolian Minsheng's net profit increasing by 11.85 times, focusing on allocations in non-ferrous metals and pharmaceuticals

Wallstreetcn
2025.08.28 14:13
portai
I'm PortAI, I can summarize articles.

The market is good, and the operations are also good